Spinocerebellar Ataxia Type 7Symptoms, Doctors, Treatments, Advances & More
Spinocerebellar Ataxia Type 7 Overview
Learn About Spinocerebellar Ataxia Type 7
View Main Condition: Movement Disorders
- Spinocerebellar ataxia 7
- ADCA, TYPE II
- Autosomal dominant cerebellar ataxia type 2
- OPCA III
- OPCA with macular degeneration and external ophthalmoplegia
- OPCA with retinal degeneration
- OPCA3
- Olivopontocerebellar atrophy 3
- SCA7
- Spinocerebellar ataxia type 7
Danny Bega is a Neurologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 17 years. Dr. Bega is rated as an Advanced provider by MediFind in the treatment of Spinocerebellar Ataxia Type 7. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Huntington Disease, Parkinson's Disease, Movement Disorders, and Wilson Disease. Dr. Bega is board certified in American Board Of Psychiatry And Neurology - Neurology (Certified). Dr. Bega is currently accepting new patients.
Victor Galvez practices practicing medicine in Mexico, Mexico. Mr. Galvez is rated as an Elite expert by MediFind in the treatment of Spinocerebellar Ataxia Type 7. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Spinocerebellar Ataxia Type 7, Olivopontocerebellar Atrophy, Spinocerebellar Ataxia, and Drug Induced Dyskinesia.
Rosalinda Diaz practices practicing medicine in Mexico City, Mexico. Ms. Diaz is rated as an Elite expert by MediFind in the treatment of Spinocerebellar Ataxia Type 7. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Spinocerebellar Ataxia Type 7, Olivopontocerebellar Atrophy, Spinocerebellar Ataxia, and Spinocerebellar Ataxia Type 5.
Summary: Spinocerebellar ataxia type 7 (SCA7) belongs to the dominant forms of inherited cerebellar ataxias (CA), being one of the rarest form. SCA7 has no therapeutic options, so that the relentless course, the important visual deficit that accompanies CA, and the possibility of disease development in childhood are pressing unmet needs. The investigators published encouraging data on riluzole in inherited...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center